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Abstract
Aims To investigate variables at the demographic and primary care practice levels that influence the uptake of diabetic
retinopathy screening.
Methods Data were extracted from the management software of one screening programme for 21 797 people
registered with 79 general practices. Uptake was examined by gender, age group, modality of screening (mobile unit at
general practice versus high-street optometrist), and by general practice. A telephone survey of high-street optometrists
provided information on the availability of screening appointments.
Results Uptake was 82.4% during the study period, and was higher for men (83.2%) than for women (81.5%)
(P = 0.001). Uptake varied by age group (P < 0.001), being lowest in those aged 12–39 years (67%). Uptake was higher
for people invited to a general practice for screening by a mobile unit (83.5%) than for those invited for screening by a
high-street optometrist (82%) (P = 0.006). After adjusting for these factors and for socio-economic deprivation score at
the location of the general practice, heterogeneity in uptake rate was still observed between some practices. Our survey
of optometrists indicated wide variation in the availability of time slots for screening during the week and of screening
appointment provision.
Conclusions Diabetic retinopathy screening services do not achieve high uptake among the youngest or oldest age
groups. Practices in the least deprived areas had the highest uptake. Variation in uptake between general practices after
adjustment for individual-level variables and deprivation suggests that practice-level factors may have an important role
in determining rates of screening attendance.
Diabet. Med. 00, 000–000 (2017)
Introduction
Diabetes mellitus is an increasing public health concern that is
estimated to affect 4.5 million people in the UK [1]. Diabetic
eye disease is an important microvascular complication of
bothType 1 andType 2 diabetes, andmay lead to visual loss if
untreated [2]. Although its incidence may be reduced through
improved blood pressure [3] and glycaemic control [4,5],
diabetic retinopathy remains the leading cause of preventable
sight loss for people of working age in the UK [6].
Non-attendance at diabetic retinopathy screening is a
major risk factor for sight-threatening retinopathy [7,8]. The
Diabetic Eye Screening Programme defines 70% as the
minimum acceptable level of uptake for the current Quality
Assurance Standard, with 80% considered achievable [9]. A
recent revision to the Quality Assurance Standard, due to
come into effect in April 2017, has increased these rates to
75% and 85%, respectively [10]. Although uptake across
England reached 81% in 2011–2012 [11], rates vary between
local screening programmes [11] and between primary care
practices within the same area [12]. Modifiable and non-
modifiable risk factors for non-attendance at diabetic
retinopathy screening are incompletely understood and
research has focused on the effects of demographic factors
at the level of the person with diabetes invited for screening.
Uptake has been found to be inversely related to socio-
economic deprivation with lower screening attendance rates
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and higher prevalence of sight-threatening retinopathy
among more deprived groups [12]. Those people least likely
to attend screening appointments are at greater risk of sight-
threatening retinopathy because they are more likely to have
other risk factors, including poor glycaemic and blood
pressure control [8]. Poor awareness of the importance of
retinopathy screening, psychological factors such as guilt due
to poor diabetic control and fear of laser treatment, and
practical barriers to attendance have also been identified as
factors reducing uptake [13].
Less evidence exists on the effects of factors occurring at
the level of general practices and optometrists on screening
uptake. A recent qualitative case-based study indicated that
general practices with high levels of social deprivation and
poorer access to screening location are less likely to achieve
higher uptake [14]. Further research into practice-level
factors influencing uptake is required to inform improve-
ments in retinopathy screening services.
The Oxfordshire Diabetic Eye Screening Programme is
unusual in delivering retinopathy screening through both
optometrist practices and mobile screening units. Mobile
units with digital retinal cameras provide screening sessions
at 22 of the 79 general practices throughout Oxfordshire,
and registered people are invited to make appointments for
screening at those practices. Those at the remaining general
practices are invited to make appointments at any one of 16
local optometrist practices. The allocation of general prac-
tices to either modality of screening is influenced by the
capacity of individual practices to host a mobile screening
unit, and by location, with rural general practices more likely
to offer screening through mobile units. The modality of
screening is the same for all registered people within each
town. Combined service delivery provides an opportunity to
compare retinopathy screening services delivered through
mobile units and optometrist practices.
In this study, we aim to investigate demographic and
primary care practice level variables that influence
retinopathy screening uptake. Variance in uptake between
general practices using either modality of screening is
analysed to examine for unexplained heterogeneity. Data
on retinopathy screening services at optometrist practices is
collected to further understand practice-level factors that
may account for variance in uptake.
Participants and methods
Analyses were performed using data extracted from the
Oxfordshire Diabetic Eye Screening Programme management
software (OptoMize, Emis Group PLC). The analysis was
restricted to the first date of invitation for each registered
person from 1 April 2012 until the end of April 2013, and
includes those newly referred to the screening programme and
those who had been invited in previous years. This 13-month
period was chosen so as to include one invitation for each
person because the screening cycle takes just over 12 months.
Data on gender, age at first invitation for screening, name and
town of registered general practice, date of invitation and date
of screening were collected for each person. Decile of Index of
Multiple Deprivation (IMD) for the postcode of each general
practice address was obtained from the Department for
Communities and Local Government [15].
Data were analysed using SAS 9.4 (SAS Institute Inc.,
Cary, NC, USA). Individual-level factors contributing to
uptake of retinopathy screening were examined with indepen-
dent chi-squared tests comparing uptake for registered people
stratified by gender, age group and modality of screening
(mobile unit at general practice versus optometrist practice).
Generalized linear mixed models (GLMM; SAS Proc
GLIMMIX) were used to examine the effect of these variables
on uptake along with IMD decile for each general practice.
General practices were fitted as random effects, and age,
gender, modality of screening and IMD group were fitted as
fixed effects. Using deciles of IMD was complicated by the
numbers of variables and levels in the model and, because
Oxfordshire is one of the least deprived areas of England, there
were very few practices in deprived areas. Deprivation at
general practice address was therefore recorded as follows:
IMDGroup 1 incorporated deciles 1–5 (most deprived), IMD
Group 2 incorporated deciles 6 and 7, IMD Group 3 incor-
porated decile 8, IMD Group 4 incorporated decile 9, and
IMD Group 5 incorporated decile 10 (least deprived).
Screening uptake at each of the 79 general practices was
determined. A funnel plot of uptake as a function of the
number of people invited for routine annual screening from
each general practice was performed to demonstrate hetero-
geneity between practices (Fig. 1).
Each of the 16 optometrist practices was contacted by
telephone during the study period and asked on which days,
and when on those days, they offered retinopathy screening
appointments, to confirm the next available appointment
from the time of the telephone call and how soon they are
usually able to offer such appointments.
What is new?
• Uptake for diabetic retinopathy screening was higher
for registered people invited for screening by a mobile
unit at a general practice than for those invited for
screening by a high-street optometrist in univariate
analysis.
• This effect disappeared in a generalized linear mixed
models analysis that included indices of socio-economic
deprivation at general practice location. These effects
have not been demonstrated previously because other
programmes do not typically deliver screening through
both modalities.
• Heterogeneity in screening uptake exists between gen-
eral practices using either modality of screening.
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Results
The Oxfordshire Diabetic Eye Screening Programme invited
21 797 people for screening during the study period and
17 967 (82.4%) attended. Overall uptake rate and uptake
rate for groups stratified by gender, age group and modality
of screening are shown in Table 1.
The number of people invited for screening at each general
practice ranged from 43 to 1236. Funnel plot analysis
(Fig. 1) indicated that significant heterogeneity in uptake
existed between general practices using either modality of
retinopathy screening (minimum, 65%; maximum, 92%).
In univariate analyses using logistic regression, uptake of
retinopathy screening was higher for men (83.2%) than for
women (81.5%) (P = 0.001). Uptake varied between groups
stratified by age (P < 0.0001), being lowest for the
12–39 years age group (67%), and increasing successively
across age groups up to 79 years (40–59 years, 78%; 60–
69 years, 87%; 70–79 years, 88%). Uptake declined in those
aged 80 years and above (79%). Uptake was higher for
people invited for screening by mobile units (83.5%) than for
those invited for screening by high-street optometrists (82%)
(P = 0.006).
Table 2 describes what are in the three GLMM. Model 3
has the best fit because it has the smallest log likelihood.
The results of the GLMM are shown in Table 3. As in the
univariate analysis, uptake varied between groups stratified
by age and was lowest in the youngest age group. In Table 3,
where IMD Group 1 are the most deprived and IMD Group
5 are the least deprived, the odds ratios show that those
people with general practitioners in the most-deprived areas
are least likely to attend for screening; IMD Group 1 (0.75,
95% confidence interval (CI), 0.58 to 0.96) compared with
IMD Group 2 (0.66, 95% CI, 0.53 to 0.96).
In contrast to the univariate analyses, gender and modality
of screening were found to have no significant effect on
uptake in the GLMM after age group and deprivation score
of general practice were included. The results of the GLMM
indicate significant heterogeneity in uptake between general
practices using either modality of screening, even after
accounting for differences in gender, age, modality of
screening and deprivation score. In the GLMM, the intra-
class correlation coefficient was 0.03, indicating that 3% of
the variability in the screening rate was accounted for by
general practices and 97% was accounted for by individual-
level or other factors. After fitting the individual-level factors
and the practice-level factors, 14 of the general practices had
a significant effect at the P = 0.05 level, and four at the
P = 0.01 level.
Our telephone survey of 16 optometrist practices indicated
heterogeneity in the availability and flexibility of appoint-
ments (Appendix 1). The time available for people wishing
to book appointments for retinopathy screening with no eye
examination varied between practices (median = 23 h/week;
minimum = 4 h, maximum = 47 h). Next-day appointments
Table 1 Uptake of screening (stratified by gender, modality of screening and age group)
No.
invited
No.
screened
Percentage
screened P-value*
Total 21 789 17 963 82.4
By gender Male 12 384 10 303 83.2 0.0011
Female 9 369 7 633 81.5
Not known 36 27 75.0
By modality of screening Mobile unit 6 530 5 454 83.5 0.0061
Optometrist 15 259 12 509 82.0
By age group 12–39 1 411 940 66.6 < 0.0001
40–59 6 039 4 727 78.3
60–69 5 455 4 763 87.3
70–79 5 352 4 727 88.3
80 and over 3 531 2 805 79.4
Not known 1 1 100.0
*Chi-squared test.
FIGURE 1 Funnel plot indicating diabetic retinopathy screening uptake
as a function of number of persons invited for screening at general
practitioner (GP) practices using both optometrist (red) and mobile unit
(blue) screening. Horizontal line indicates mean uptake across all GP
practices. Outer dashed lines indicate limits of variance from the mean
to 2 SD and 3 SD.
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for retinopathy screening were offered by four optometrist
practices, and two practices stated that they were usually
able to offer appointments within 48 h. Most optometrist
practices (n = 10) were able to offer appointments within
1 week. One optometrist practice (practice A) could only
offer appointments in 4 weeks’ time. Weekend appointments
were offered by 10 optometrist practices and one practice
stated that they would consider offering a screening appoint-
ment outside normal opening hours.
Discussion
Oxfordshire Diabetic Eye Screening Programme achieved an
overall screening uptake of 82.4% during the study period.
Although this rate is above that defined as achievable by the
current Quality Assurance Standard and is just below the
achievable rate in the new Quality Standard, it indicates that
a significant minority of those invited did not attend
screening. These non-attenders are likely to be young people,
in whom a longer time interval between diabetic registration
and attendance for screening results in greater risk of
referable retinopathy being present at the time of first
screening [8].
Consistent with previous studies [16–19], rates of atten-
dance were lowest in the youngest age group. Lower uptake
in this group represents a lost opportunity to limit the
progression of disease because younger people are at highest
risk of developing future retinopathy [18]. As well as
increased risk of visual loss, the progression of sight-
threatening retinopathy in young people engenders huge
socio-economic cost to society. Despite the trend of higher
uptake with increasing age, the reduction in attendance rates
in those aged over 80 years may relate to reduced mobility or
comorbidity limiting access to diabetic retinopathy screening
services.
Our analysis of the effect of individual-level factors on
uptake benefits from being based on a dataset of all
registered people invited for retinopathy screening over
1 year. Data on ethnicity and measurements of blood
pressure and glycaemic control for people in our study group
were not available to the screening programme and we were
thus unable to analyse the effect of these factors.
Uptake was higher for those invited for screening by
mobile units than for those invited for screening by a high-
street optometrist. However, this effect disappeared in the
GLMM that included indices of socio-economic deprivation
at the general practice location, reflecting the fact that
registered people in more deprived locations are more likely
to be offered screening by a high-street optometrist than by a
mobile unit. These effects have not been demonstrated
Table 2 Estimates for 2 level generalized dichotomous models of screening uptake
Model 1 Model 2 Model 3
Fixed effects
Intercept 1.55 (0.04) 1.40 (0.07) 1.63 (0.09)
Age group Yes Yes
Gender Yes Yes
Modality of screening Yes Yes
Index of Multiple Deprivation group of general practice Yes
Error variance
Level 2 intercept 0.114 (0.026) 0.099 (0.023) 0.080 (0.021)
Model fit
Model fit – twice the log likelihood 2024.6 1468.6 1462.5
Table 3 Results of the generalized mixed models analysis
Odds ratio 95% CI P-value
Age group 12–39 0.52 0.45 to 0.60 < 0.0001
40–59 0.95 0.85 to 1.05 0.29
60–69 1.76 1.56 to 1.98 < 0.0001
70–79 1.96 1.74 to 2.21 < 0.0001
Gender Female 0.91 0.85 to 0.98 0.014
Male Reference
Modality of screening Mobile unit 0.99 0.83 to 1.18 0.88
Optometrist Reference
General practice Index of
Multiple Deprivation score
Group 1 0.75 0.58 to 0.96 0.02
Group 2 0.66 0.53 to 0.96 < 0.0001
Group 3 0.80 0.63 to 1.02 0.070
Group 4 0.82 0.66 to 1.01 0.063
Group 5 Reference
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previously because other screening programmes do not
typically deliver screening through both modalities. Although
the difference in overall uptake between the two screening
modalities is small in both univariate analysis and the
GLMM, the clinical relevance of this finding relates to
optometrists having argued that they offer a wider range of
services in terms of possible timings of screening appoint-
ments than a mobile screening service. However, the range of
services offered by individual optometrist practices within
Oxfordshire is highly variable and, given this variation, no
increase in uptake within optometrist practices has been
demonstrated in this study.
The results of our telephone questionnaire suggest that
some of the variance in uptake between those invited for
optometrist screening may be due to variation in the
availability and flexibility of screening appointments offered
by optometrists in different locations. As noted in the case of
‘practice A’, limited availability of time slots for screening
during the week correlated with long waiting times for
appointments. Such data are valuable in evaluating screening
service provision in different locations.
Consistent with previous studies [12], we found that
uptake rates for screening remain lower at practices located
in areas of higher socio-economic deprivation. Oxfordshire
Diabetic Eye Screening Programme needs to encourage
uptake among socio-economically deprived groups because
these people are at the highest risk of sight-threatening
diabetic retinopathy. IMD score includes the Education,
Skills and Training Deprivation Domain which measures the
lack of attainment and skills in the local population. Further
work should include efforts to determine how one may
engage more effectively with those who have a lower
educational level, particularly those with poor literacy,
health literacy and numeracy.
It is our opinion that general practice likely has a greater
effect on screening attendance of registered persons than does
the modality of screening they attend. Heterogeneity in
screening uptake exists between general practices using either
modality of retinopathy screening (see Fig. 1), and this
remains true even after adjusting for socio-economic depri-
vation at the location of the general practice. Although
previous studies note greater variance in uptake between
general practices than would be expected based on their
respective local populations [12], we are unaware of any that
have demonstrated such variance quantitatively at a practice
level. Variance likely relates to complex interactions between
modifiable and non-modifiable risk factors for non-atten-
dance [14].
When looking at four practices individually, three with
lower uptake and one with higher uptake, factors that
appeared to influence practice uptake apart from socio-
economic factors were: the convenience of the screening
location, with ease of parking near the location; minority
language barriers; and general interest taken by the practice
in diabetes care. Within the group who were socio-
economically disadvantaged, it was notable that poor areas
of Oxford are served by optometrists, but optometrist
practices are not generally located in the poorer parts of
the city.
Identifying general practices achieving low levels of uptake
provides a basis for further work to assess modifiable risk
factors for non-attendance and implement interventions
where required. This further work could include examining
whether screening uptake varies with practice-level factors
such as uptake of patient education resources, the provision
of diabetes specialist nurses, whether there is a general
practitioner responsible for people with diabetes at the
practice, and who registered persons routinely see at the
practice for diabetes care.
In conclusion, this study has indicated that existing
diabetic retinopathy screening service provision by Oxford-
shire Diabetic Eye Screening Programme may not be
effective at achieving high uptake among the youngest or
oldest age groups. Uptake rates for screening are lower at
practices located in areas of higher socio-economic depri-
vation. Uptake rates have not been found to be higher for
those accessing screening services via high-street optome-
trists, despite this modality of screening being thought to
offer increased appointment flexibility above that of mobile
units. Significant unexplained heterogeneity in uptake
between general practices using either modality of
retinopathy screening suggests that practice-level factors
may have an important role in determining rates of
attendance. Further work should be aimed at determining
the extent to which this variance can be accounted for by
modifiable practice-level factors that may be amenable to
intervention.
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Appendix 1 Optometrist survey data
A B C D E F G H I J K L M N O P
Q1 8 15 46.5 42.5 30 32.5 25.5 34 8 14 3.75 22.75 22.5 16 36.5 15
Q2 No Yes Yes Yes No Yes Yes No Yes No Yes No Yes No Yes Yes
Q3 35 5 4 1 11 10 3 2 5 3 1 3 1 10 1 7
Q4 > 1 month
(4-6 weeks
typically)
< 1
week
< 1
week
< 48 h > 1
week
< 1 week > 1
week
< 48 h > 1 week
(7–8 days
typically)
< 1
week
< 1
week
> 1
week
< 1
week
> 1
week
< 1
week
< 1
week
Q5 Yes No No Yes Yes Yes Yes Yes No Yes No Yes No No No Yes
Q6 No No No No No No No No No No No No No No No Yes
Overall
score
2 6 11 11 7 9 9 9 5 6 4 7 7 4 9 7
A to P, Optometrist practices that responded to the telephone survey (anonymized).
Q1: Estimate the total shop hours per week available to book diabetic retinopathy screening appointments. Q2: Are screening appointments ever available at weekends? Q3: When is the first
appointment that you could offer me for diabetic retinopathy screening (number of practice days)? Q4: How quickly are you typically able to offer people an appointment when they contact you?
Q5: Would you consider flexible appointments outside the normal shop hours that you currently offer for diabetic retinopathy screening? Q6: Would you consider flexible appointments outside
normal shop opening hours for diabetic retinopathy screening?
Overall score – sum of days available: +1 (if screening available at weekend); +3 (if screening available within 1 week); +2 (if screening available in 2 weeks); +1 (if screening possible outside normal
diabetic retinopathy screening hours).
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